Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology Drug Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107746861A details a biocatalytic route for high-purity chiral alcohols. Discover cost-effective supply chain solutions for API intermediates.
Novel decarboxylation route for FGFR inhibitor intermediate offers high yield and purity. Ideal for cost reduction in API manufacturing and scalable supply chains.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Advanced synthesis of 5-(4-methyl-1H-imidazol-1-yl)-3-trifluoromethyl-aniline via patent CN102174020B. Delivers superior purity, safety, and cost efficiency for kinase inhibitor supply chains.
Patent CN113773241A details a novel Pd/Al2O3 catalytic route for N-methyl indole, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102180836B reveals a safer, cost-effective method for synthesizing kinase inhibitor intermediates, offering significant supply chain advantages.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN100537563C reveals a streamlined acid-catalyzed condensation for N-phenyl-2-pyrimidinamine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Patent CN112724089B details a high-yield bromination process for 2-amino-3-bromo-6-chloropyrazine, offering significant cost reduction and scalable production for SHP2 inhibitor intermediates.
Patent CN108101857B details a high-yield route for 2-amino-3-bromo-6-chloropyrazine, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102558098A reveals a cost-effective one-pot synthesis for EGFR inhibitor intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN102558098A details a one-pot synthesis for EGFR inhibitor intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Patent CN113636973B reveals a green industrial method for Palbociclib intermediates, offering high purity, cost reduction, and scalable manufacturing for global supply chains.
Patent CN1247573C reveals a high-yield route for CDK inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN107011134B reveals a streamlined lithiation-acetylation route for 2-fluoro-5-bromoacetophenone, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel method for 4-aminoazaindole ketones via rearrangement and oxidation-reduction. Offers mild conditions and high purity for drug discovery.
Patent CN115353519A reveals a novel IBX oxidation route for BTK inhibitor intermediates, offering >99.5% purity and eliminating costly column chromatography for scalable manufacturing.